Microsomal epoxide hydrolase polymorphisms, cigarette smoking and prostate cancer risk in the Slovak population.

Polymorphisms in tobacco carcinogen metabolizing enzymes may generate interindividual variations towards the risk of developing prostate cancer. One of these enzymes is microsomal epoxide hydrolase (EPHX1) which metabolizes polycyclic aromatic hydrocarbons, or PAH, carcinogens found in cigarette smoke. The activity of this enzyme is affected by two polymorphisms, a substitution of Tyr113 by His in exon 3 and a substitution of His139 by Arg in exon 4. The aim of this study was to use a population-based case-control study to investigate whether or not such genetic polymorphisms in EPHX1 gene can modify the relationship between smoking status and the risk of developing prostate cancer. We used restriction fragment length polymorphism, or PCR-RFLP to determine EPHX1 genotypes in subjects comprising 194 patients with histologically verified prostate cancer and 305 healthy individuals as control. We found no overall association between prostate cancer risk and functional polymorphisms of EPHX1 gene in exon 3 and exon 4. We further analysed the association between the EPHX1 genotypes and smoking. Smokers carrying the exon 3 Tyr/Tyr and Tyr/His genotypes were at no significant risk compared to non-smokers with the "rapid" Tyr/Tyr genotype. By contrast, a significant interaction of smoking and the exon 4 polymorphism was present.

[1]  G. Gulis,et al.  Trends in Prostate Cancer Incidence and Mortality before and after the Introduction of PSA Testing in the Slovak and Czech Republics , 2011 .

[2]  J. Bouchal,et al.  Genetic determinants of prostate cancer: a review. , 2011, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[3]  Fritz H Schröder,et al.  Prostate cancer around the world. An overview. , 2010, Urologic oncology.

[4]  M. Widersten,et al.  Structure-function relationships of epoxide hydrolases and their potential use in biocatalysis. , 2010, Biochimica et biophysica acta.

[5]  Nilanjan Chatterjee,et al.  Phase I Metabolic Genes and Risk of Lung Cancer: Multiple Polymorphisms and mRNA Expression , 2009, PloS one.

[6]  N. Duale,et al.  Biomarkers of Human Exposure to Acrylamide and Relation to Polymorphisms in Metabolizing Genes , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[7]  R. Tkacova,et al.  Glutathione S-transferase and microsomal epoxide hydrolase gene polymorphisms and risk of chronic obstructive pulmonary disease in Slovak population. , 2008, Croatian medical journal.

[8]  S. Ahmed,et al.  Implication of Xenobiotic Metabolizing Enzyme gene (CYP2E1, CYP2C19, CYP2D6, mEH and NAT2) Polymorphisms in Breast Carcinoma , 2008, BMC Cancer.

[9]  R. D. Mittal,et al.  Cytochrome P4501A1 and microsomal epoxide hydrolase gene polymorphisms: gene-environment interaction and risk of prostate cancer. , 2007, DNA and cell biology.

[10]  N. Nock,et al.  Associations between Smoking, Polymorphisms in Polycyclic Aromatic Hydrocarbon (PAH) Metabolism and Conjugation Genes and PAH-DNA Adducts in Prostate Tumors Differ by Race , 2007, Cancer Epidemiology Biomarkers & Prevention.

[11]  S. Cox,et al.  Etiological study of esophageal squamous cell carcinoma in an endemic region: a population-based case control study in Huaian, China , 2006, BMC Cancer.

[12]  J. Witte,et al.  Polymorphisms in Polycyclic Aromatic Hydrocarbon Metabolism and Conjugation Genes, Interactions with Smoking and Prostate Cancer Risk , 2006, Cancer Epidemiology Biomarkers & Prevention.

[13]  Tsutomu Shimada,et al.  Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons. , 2006, Drug metabolism and pharmacokinetics.

[14]  C. Ulrich,et al.  Microsomal Epoxide Hydrolase Polymorphisms Are Not Associated with Colon Cancer Risk , 2005, Cancer Epidemiology Biomarkers & Prevention.

[15]  R. Hayes,et al.  Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma. , 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[16]  S. Sankey,et al.  Polycyclic Aromatic Hydrocarbon-DNA Adducts in Prostate Cancer , 2004, Cancer Research.

[17]  D. Hunter,et al.  Epoxide hydrolase polymorphisms, cigarette smoking and risk of colorectal adenoma in the Nurses' Health Study and the Health Professionals Follow-up Study. , 2004, Carcinogenesis.

[18]  P. Yang,et al.  Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD , 2004, European Respiratory Journal.

[19]  M. Eichelbaum,et al.  Distribution of Microsomal Epoxide Hydrolase in Humans: An Immunohistochemical Study in Normal Tissues, and Benign and Malignant Tumours , 2001, The Histochemical Journal.

[20]  D. Jerina,et al.  r-1,t-2,3,c-4-Tetrahydroxy-1,2,3,4-tetrahydrophenanthrene in human urine: a potential biomarker for assessing polycyclic aromatic hydrocarbon metabolic activation. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[21]  K Trieb,et al.  Association of microsomal epoxide hydrolase polymorphisms and lung cancer risk , 2003, British Journal of Cancer.

[22]  M. Watson,et al.  NQO1 and mEH exon 4 (mEH4) gene polymorphisms, smoking and colorectal cancer risk. , 2002, IARC scientific publications.

[23]  J. Gómez-catalán,et al.  Lung cancer susceptibility in relation to combined polymorphisms of microsomal epoxide hydrolase and glutathione S-transferase P1. , 2001, Cancer letters.

[24]  D. Levy,et al.  A case-control study of microsomal epoxide hydrolase, smoking, meat consumption, glutathione S-transferase M3, and risk of colorectal adenomas. , 2001, Cancer research.

[25]  C J Omiecinski,et al.  Epoxide hydrolases: biochemistry and molecular biology. , 2000, Chemico-biological interactions.

[26]  S. London,et al.  Lung cancer risk in relation to genetic polymorphisms of microsomal epoxide hydrolase among African-Americans and Caucasians in Los Angeles County. , 2000, Lung cancer.

[27]  V. Hosagrahara,et al.  Epoxide hydrolase--polymorphism and role in toxicology. , 2000, Toxicology letters.

[28]  H. Autrup.  Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response. , 2000, Mutation research.

[29]  J. S. Sidhu,et al.  Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. , 1994, Human molecular genetics.

[30]  F. Oesch,et al.  Sequence similarity of mammalian epoxide hydrolases to the bacterial haloalkane dehalogenase and other related proteins , 1994, FEBS letters.

[31]  O. Mcbride,et al.  Human microsomal xenobiotic epoxide hydrolase. Complementary DNA sequence, complementary DNA-directed expression in COS-1 cells, and chromosomal localization. , 1988, The Journal of biological chemistry.